Lisa McNeill joined AAHI in late 2007. With more than twenty-five years of assay development and quality control experience in pharmaceutical and biotechnology companies in the United States, she is the Director of Manufacturing at AAHI. Her primary responsibilities consist of leading her group of seven staff members in GMP lot release and stability testing of parenteral products, assay development, environmental monitoring and management of outsourced contract laboratory testing. Prior to joining AAHI, McNeill served as a Senior Scientist in Quality Control for Dharma Therapeutics, a manufacturer of iontophoretic transdermal patches, from 2005. She came to Dharma from Xcyte Therapies, a T Cell therapy company, where she managed the Assay Development group, working on test methods for characterization of T cells, antibodies and magnetic bead-captured antibodies. Previously, McNeill held a lab management position for almost ten years in Bill Harris’s developmental neurobiology laboratory at the University of California, San Diego, with a focus on Xenopus laevis retinal neuron pathfinding and targeting. McNeill received her BA in Animal Physiology from the Revelle College at the University of California, San Diego.